Retail

United States Walmart Tender

📄 Tender ID: 463480123 📅 Published: 30 Jun 2021

📋 Tender Overview

Walmarts exclusive ReliOn NovoLog vials and FlexPens will save customers 58 to 75 off the cash price of branded insulin products.Walmart announced the launch of the first-ever private brand analog insulin which will revolutionize the access and affordability to diabetes care by offering customers a significant price savings without compromising quality. Available exclusively through Walmarts private ReliOn brand the new offering includes analog insulin vials 72.88 and FlexPen 85.88. These products will save customers1 between 58 to 75 off the cash price of branded analog insulin products which translates to a savings of up to 101 per branded vial or 251 per package of branded FlexPens.The new private label ReliOn NovoLog Insulin insulin aspart injection manufactured by Novo Nordisk is available in Walmart pharmacies this week and Sams Club pharmacies in mid-July across the United States. ReliOn NovoLog is a rapid-acting insulin analog used to control high blood sugar in adults and children with diabetes. Customers will need a prescription in order to purchase the products and should always consult with their doctor regarding their diabetes management.We know many people with diabetes struggle to manage the financial burden of this condition and we are focused on helping by providing affordable solutions. We also know this is a condition that disproportionately impacts underserved populations. With ReliOn NovoLog insulin were adding a high-quality medication for diabetes to the already affordable ReliOn line of products and continuing our commitment to improve access and lowering cost of care said Dr. Cheryl Pegus executive vice president Walmart Health Wellness.Walmart is a destination for affordable diabetes resources including blood glucose monitors lancets and other diabetes management essentials in the ReliOn portfolio. Notably the retailers suite of affordable diabetes products offers customers choices when it comes to their diabetes management however every patient is unique and may respond differently to treatment so the ultimate treatment decision should be based on their health care providers recommendation.Diabetes often comes with high medical costs estimated around 9601 per person per year. We welcome all affordable solutions that make diabetes management more accessible to millions of Americans living with diabetes. We encourage everyone to ask their health care provider questions to better understand what the right and affordable treatment is for their unique medical needs said Tracey D. Brown chief executive officer of the American Diabetes Association.The ReliOn NovoLog analog insulin offering adds to Walmarts history of introducing innovative solutions that increase access to quality affordable health care resources including the industry-leading 4 generic prescription program launched more than a decade ago.

🔍 Key Information

📄
Tender Reference No.
463480123
📅
Publication Date
30 Jun 2021
🌐
Sector
Retail
📝
Notice Type
News
📍
Location
United states

📁 Documents & Downloads

No documents found

🏷️ CPV

No CPV found

Need help with this bid?

Our bid experts can help you find, evaluate & win more tenders.

🎧 Talk to Bid Expert
🕒 Submission deadline
0
days remaining · 30 Jun 2021
🔔 Set Alert

🧭 Quick Facts

Authority N/A
Country United states
State / UT N/A
Tender Type Procurement News
Currency N/A
Similar Tenders
Loading similar tenders…